Skip to main content
NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.681
-0.039 (-5.42%)
At close: Nov 22, 2024, 4:00 PM
0.671
-0.010 (-1.42%)
After-hours: Nov 22, 2024, 7:34 PM EST

NovaBay Pharmaceuticals Revenue

NovaBay Pharmaceuticals had revenue of $2.44M in the quarter ending September 30, 2024, a decrease of -1.61%. This brings the company's revenue in the last twelve months to $13.84M, up 15.40% year-over-year. In the year 2023, NovaBay Pharmaceuticals had annual revenue of $14.73M with 2.24% growth.

Revenue (ttm)
$13.84M
Revenue Growth
+15.40%
P/S Ratio
0.07
Revenue / Employee
$532,462
Employees
26
Market Cap
3.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.73M322.00K2.24%
Dec 31, 202214.40M4.20M41.16%
Dec 31, 202110.20M270.00K2.72%
Dec 31, 20209.93M3.34M50.54%
Dec 31, 20196.60M-5.91M-47.24%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

NBY News

More News